WINDLAS

Windlas Biotech Share PriceWindlas Biotech

₹225.00
0.25 (0.11%)
As on 31 March, 2023 | 22:27 BSE: 543329 NSE: WINDLAS

Windlas Biotech Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Windlas Biotech

Start SIP

Windlas Biotech Share Price

  • Over 1 Month -11.82%
  • Over 3 Month -10.04%
  • Over 6 Month -3.91%
  • Over 1 Year 7.12%

Windlas Biotech Key Statistics

P/E Ratio 10.4
PEG Ratio 0.2
Market Cap Cr 480
Price to Book Ratio 1.2
EPS 18.1
Dividend 1.6
Relative Strength Index 26.87
Money Flow Index 33.61
MACD Signal -3.56
Average True Range 6.46

Windlas Biotech Investment Rating

  • Master Rating:
  • Windlas Biotech has an operating revenue of Rs. 494.50 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 10% is healthy, ROE of 9% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 56 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Windlas Biotech Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 120133120122
Operating Expenses Qtr Cr 106117106108
Operating Profit Qtr Cr 14161414
Depreciation Qtr Cr 3333
Interest Qtr Cr 0000
Tax Qtr Cr 434-1
Net Profit Qtr Cr 9121015

Windlas Biotech Technicals

EMA & SMA

Current Price
₹225.
0.25 (0.11%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 239.25
  • 50 Day
  • 244.26
  • 100 Day
  • 244.62
  • 200 Day
  • 247.8
  • 20 Day
  • 242.19
  • 50 Day
  • 246.32
  • 100 Day
  • 248.65
  • 200 Day
  • 237.1

Windlas Biotech Resistance and Support

PIVOT
₹223.77
Resistance
First Resistance 226.99
Second Resistance 229.22
Third Resistance 232.44
RSI 26.87
MFI 33.61
MACD Single Line -3.56
MACD -5.81
Support
First Resistance 221.54
Second Resistance 218.32
Third Resistance 216.09

Windlas Biotech Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 22,071 1,539,452 69.75
Week 21,176 1,492,502 70.48
1 Month 22,594 1,570,704 69.52
6 Month 41,160 2,650,271 64.39

Windlas Biotech Result Highlights

Windlas Biotech Synopsis

NSE-Medical-Ethical Drugs

Windlas Biotech belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 465.93 Cr. and Equity Capital is Rs. 10.90 Cr. for the Year ended 31/03/2022. Windlas Biotech Ltd. is a Public Limited Listed company incorporated on 19/02/2001 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company’s Corporate Identification Number(CIN) is L74899UR2001PLC033407 and registration number is 033407.
Market Cap 481
Sales 495
Shares in Float 0.83
No of funds 15
Yield 1.56
Book Value 1.24
U/D Vol ratio 0.9
LTDebt / Equity
Alpha 0.05
Beta 0.73

Windlas Biotech

Owner NameFeb-23Dec-22Sep-22Jun-22
Promoters 61.22%60.75%59.95%
Mutual Funds 11.32%11.39%10.89%
Insurance Companies 0.08%
Foreign Portfolio Investors 1.4%1.45%2.19%
Financial Institutions/ Banks 0.04%0.04%0.04%
Individual Investors 22.18%22.7%22.98%
Others 3.84%3.67%3.95%

Windlas Biotech Management

Name Designation
Mr. Vivek Dhariwal Chairman & Ind.Director
Mr. Hitesh Windlass Managing Director
Mr. Manoj Kumar Windlass Joint Managing Director
Mr. Pawan Kumar Sharma Executive Director
Mr. Ashok Kumar Windlass Whole Time Director
Mrs. Prachi Jain Windlass Non Executive Director
Mr. Srinivasan Venkataraman Ind. Non-Executive Director
Mr. Gaurav Gulati Ind. Non-Executive Director

Windlas Biotech Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Windlas Biotech MF Shareholding

Name Amount(cr)
ICICI Prudential Smallcap Fund Growth 4618
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 2538
UTI Small Cap Fund Regular Growth 2391
UTI Healthcare Fund Regular Plan Growth 655
Sundaram Emerging Small Cap Ser VII Regular Transfer Inc Dist cum Cap Wdrl 141

Windlas Biotech FAQs

What is Share Price of Windlas Biotech ?

Windlas Biotech share price is ₹225 As on 31 March, 2023 | 22:13

What is the Market Cap of Windlas Biotech ?

The Market Cap of Windlas Biotech is ₹480.2 Cr As on 31 March, 2023 | 22:13

What is the P/E ratio of Windlas Biotech ?

The P/E ratio of Windlas Biotech is 10.4 As on 31 March, 2023 | 22:13

What is the PB ratio of Windlas Biotech ?

The PB ratio of Windlas Biotech is 1.2 As on 31 March, 2023 | 22:13

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number